TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17051490

Group type: EXPERIMENTAL
Intervention: Azithromycin (750 mg twice daily) + Artesunate (100 mg twice daily)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Azithromycin (1000 mg once daily) + Artesunate (200 mg once daily)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg 3 times daily) + Quinine (10 mg/kg 3 times daily)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Azithromycin (750 mg twice daily) + Quinine (10 mg/kg twice daily)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Artesunate combinations
Number of subjects: 100

Group type: COMPARATOR
Intervention: Quinine cohorts
Number of subjects: 100
Study: 12743434

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg
Number of subjects: 669

Group type: COMPARATOR
Intervention: Omeprazole MUPS 40 mg
Number of subjects: 669
Study: 11187917

Group type: EXPERIMENTAL
Intervention: Omission of cyclophosphamide in standard risk patients (trial 58831)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omission of radiotherapy in medium- and high-risk patients (trial 58832)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of high-dose cytarabine with high-dose methotrexate during interval therapy (trial 58881)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Addition of 6-mercaptopurine iv during maintenance (trial 58881)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: E. coli asparaginase (trial 58881)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leukocyte counts >100 x 10(9)/l, specific genetic abnormalities, poor initial response to steroids, high level of minimal residual disease (trial 58881)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall event-free survival (EFS) rates at 6 years (trial 58831/32)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall event-free survival (EFS) rates at 10 years (trial 58831/32)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risk of isolated CNS relapse at 6 years (trial 58831/32)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risk of isolated CNS relapse at 10 years (trial 58831/32)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall EFS rate at 8 years (trial 58881)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risk of isolated CNS relapse at 8 years (trial 58881)
Number of subjects: 0
Study: 9088058

Group type: EXPERIMENTAL
Intervention: Feedback plus fading condition
Number of subjects: 45

Group type: COMPARATOR
Intervention: Feedback condition
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control condition (experience in making judgments without feedback)
Number of subjects: 45
Study: 8466005

Group type: EXPERIMENTAL
Intervention: 0.9 micrograms.kg‐1.min‐1 of intravenous nitroglycerin
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 3923833

Group type: EXPERIMENTAL
Intervention: Glyburide (GL)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chlorpropamide (CP)
Number of subjects: 20
Study: 29422463

Group type: EXPERIMENTAL
Intervention: Toothbrush with crisscross bristles
Number of subjects: 45
Study: 28071044

Group type: EXPERIMENTAL
Intervention: 3.0 g/d CLA for 12 weeks
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo (sunflower oil) for 12 weeks
Number of subjects: 74
Study: 23670305

Group type: EXPERIMENTAL
Intervention: SBR759 (3‐, 6‐, 9‐, 12‐g/day)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (12‐g/day)
Number of subjects: 63
Study: 22581148

Group type: EXPERIMENTAL
Intervention: Mini-posterior approach for THA
Number of subjects: 100

Group type: COMPARATOR
Intervention: Posterolateral approach for THA
Number of subjects: 100
Study: 20607878

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided peripheral nerve block
Number of subjects: 20
Study: 18759356

Group type: EXPERIMENTAL
Intervention: CP-101,606 (NR2B selective NMDA glutamate antagonist)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 15821528

Group type: EXPERIMENTAL
Intervention: Duloxetine (80 mg daily) + Pelvic Floor Muscle Training (PFMT)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Combined treatment (Duloxetine + PFMT)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Duloxetine alone
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: PFMT alone
Number of subjects: 201

Group type: COMPARATOR
Intervention: No active treatment
Number of subjects: 201

Group type: COMPARATOR
Intervention: Imitation PFMT
Number of subjects: 201
Study: 12555017

Group type: EXPERIMENTAL
Intervention: Pancreatic stenting
Number of subjects: 0
Study: 10501366

Group type: EXPERIMENTAL
Intervention: Intensive case management
Number of subjects: 700

Group type: COMPARATOR
Intervention: Standard case management
Number of subjects: 700
Study: 8941813

Group type: EXPERIMENTAL
Intervention: Gallium alloy (Gallium alloy GF)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Amalgam (Dispersalloy)
Number of subjects: 28
Study: 1681224

Group type: EXPERIMENTAL
Intervention: Long-acting chloramphenicol (double injection on admission and 48 hours later)
Number of subjects: 528

Group type: COMPARATOR
Intervention: Intravenous ampicillin (8 days, 4 times a day)
Number of subjects: 528
Study: 6619812

Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of inactivated hepatitis B vaccine (20 micrograms) by automatic jet injection
Number of subjects: 19

Group type: COMPARATOR
Intervention: Saline placebo injections
Number of subjects: 19
Study: 30920084

Group type: EXPERIMENTAL
Intervention: Pain severity
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sleep quality
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sleep quality (mediator)
Number of subjects: 80
Study: 29120986

Group type: EXPERIMENTAL
Intervention: Capsaicin (12 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 27271657

Group type: EXPERIMENTAL
Intervention: IMHP with β‐glucan
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: IMHP without β‐glucan
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study: 24149934

Group type: EXPERIMENTAL
Intervention: High-concentration of air ions (ION: 220 ± 30 × 10(3) ions cm(‐3))
Number of subjects: 14

Group type: COMPARATOR
Intervention: Normal room conditions (PLA: 0.1 ± 0.06 × 10(3) ions cm(‐3))
Number of subjects: 14
Study: 21968360

Group type: EXPERIMENTAL
Intervention: Tigecycline (100 mg loading dose followed by 50 mg every 12 h)
Number of subjects: 0
Study: 19793213

Group type: EXPERIMENTAL
Intervention: CORT (Corticosteroid injections)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: ECC (Eccentric decline squat training)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: HSR (Heavy slow resistance training)
Number of subjects: 39
Study: 17999899

Group type: EXPERIMENTAL
Intervention: Thrombolytic drugs administered intraventricularly through an external ventricular drain
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 15066925

Group type: EXPERIMENTAL
Intervention: Ovarian cancer screening consisting of serum CA125 alternating with TVS performed semiannually over 18 months
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Ovarian cancer risk education
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Follow-up telephone calls consisting of up to four reminder messages
Number of subjects: 292
Study: 12418394

Group type: EXPERIMENTAL
Intervention: Copaxone (glatiramer acetate)
Number of subjects: 32
Study: 9809092

Group type: EXPERIMENTAL
Intervention: 1.5 ml of 0.5% hyperbaric bupivacaine solution
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 2 ml of 0.5% hyperbaric bupivacaine solution
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 2.5 ml of 0.5% hyperbaric bupivacaine solution
Number of subjects: 90
Study: 7534838

Group type: EXPERIMENTAL
Intervention: Combined aprotinin (200 KIU) and prostaglandin E1 (0.01‐0.02 microgram/kg/min) during cardiopulmonary bypass and the first postoperative day
Number of subjects: 20

Group type: COMPARATOR
Intervention: No treatment (Control group B)
Number of subjects: 20
Study: 2793459

Group type: EXPERIMENTAL
Intervention: Autogenic phases group
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Electromyographic biofeedback group
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Thermal training group
Number of subjects: 42
Study: 31505302

Group type: EXPERIMENTAL
Intervention: Local retropharyngeal steroids
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control (no retropharyngeal steroids)
Number of subjects: 121
Study: 31362883

Group type: EXPERIMENTAL
Intervention: Fentanyl (25μg) added to bupivacaine (1mL bupivacaine 0.5%)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (5μg) added to bupivacaine (1mL bupivacaine 0.5%)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline (0.5mL) added to bupivacaine (1mL bupivacaine 0.5%)
Number of subjects: 90
Study: 28494643

Group type: EXPERIMENTAL
Intervention: Early specialist palliative care
Number of subjects: 297

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 297
Study: 26495971

Group type: EXPERIMENTAL
Intervention: Brain-Machine Interface (BMI) training with robotic orthosis to move the paretic limb
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham group with random orthosis movements
Number of subjects: 32
Study: 22320714

Group type: EXPERIMENTAL
Intervention: 5000 ppm F; twice a day
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 5000 ppm; 3‐times/day
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 5000 ppm; twice a day, plus the 'massage' method once a day
Number of subjects: 16

Group type: COMPARATOR
Intervention: 1450 ppm F; twice a day
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1450 ppm; 3‐times/day
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1450 ppm; twice a day, plus the 'massage' method once a day
Number of subjects: 16
Study: 21490522

Group type: EXPERIMENTAL
Intervention: S-ketamine infusion at 2 μg · kg · min for 3 hrs
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo infusion at equivalent rate for 3 hrs
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: S-ketamine infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 10
Study: 19515630

Group type: EXPERIMENTAL
Intervention: Atosiban
Number of subjects: 45

Group type: COMPARATOR
Intervention: Ritodrine
Number of subjects: 45
Study: 17668562

Group type: EXPERIMENTAL
Intervention: Immediate treatment switch
Number of subjects: 47

Group type: COMPARATOR
Intervention: Delayed treatment switch
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study: 15112118

Group type: EXPERIMENTAL
Intervention: Focal hand dystonia (FHD) subjects
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 20
Study: 11125195

Group type: EXPERIMENTAL
Intervention: 5,000 ppm fluoride dentifrice (Prevident 5000 Plus)
Number of subjects: 201

Group type: COMPARATOR
Intervention: 1,100 ppm fluoride dentifrice (Winterfresh Gel)
Number of subjects: 201
Study: 9586886

Group type: EXPERIMENTAL
Intervention: Interferon alfa 8 million U subcutaneously daily
Number of subjects: 108

Group type: COMPARATOR
Intervention: Interferon alfa 1 million U subcutaneously daily
Number of subjects: 108
Study: 7774334

Group type: EXPERIMENTAL
Intervention: Flow Triggering (FT) with the 7200ae ventilator
Number of subjects: 10

Group type: COMPARATOR
Intervention: Pressure Triggering (PT) with the 7200ae ventilator
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Flow Triggering (FT) with the Veolar ventilator
Number of subjects: 10

Group type: COMPARATOR
Intervention: Pressure Triggering (PT) with the Veolar ventilator
Number of subjects: 10
Study: 3132930

Group type: EXPERIMENTAL
Intervention: Intravenous lipid infusion alone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lipid with amino acids
Number of subjects: 15

Group type: COMPARATOR
Intervention: Amino acids alone
Number of subjects: 15
Study: 28634748

Group type: EXPERIMENTAL
Intervention: Ramucirumab 8 mg/kg in combination with 80 mg/m2 paclitaxel
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo in combination with 80 mg/m2 paclitaxel
Number of subjects: 222
Study: 27056606

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 24055281

Group type: EXPERIMENTAL
Intervention: Transgastric echocardiography
Number of subjects: 21
Study: 22901843

Group type: EXPERIMENTAL
Intervention: Low-calorie diet with carbohydrates eaten at dinner
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard low-calorie diet
Number of subjects: 78
Study: 21122391

Group type: EXPERIMENTAL
Intervention: Interleukin-11 (50 µg × kg(‐1) × d(‐1))
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no interleukin-11)
Number of subjects: 70
Study: 17451667

Group type: EXPERIMENTAL
Intervention: Serial model (MOMIT) for tracking multiple moving objects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mathematical version of MOMIT
Number of subjects: 0
Study: 16710029

Group type: EXPERIMENTAL
Intervention: Low-fat diet intervention
Number of subjects: 741

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 741
Study: 12820332

Group type: EXPERIMENTAL
Intervention: Adjuvant autologous tumor cell lysate vaccine
Number of subjects: 236
Study: 11242724

Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate (MTA)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Formocresol (FC)
Number of subjects: 26
Study: 9211627

Group type: EXPERIMENTAL
Intervention: Isradipine (5mg daily for 4 weeks)
Number of subjects: 40
Study: 7970862

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2823859

Group type: EXPERIMENTAL
Intervention: 10 g of fish oil daily (1.8 g eicosapentaenoic acid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo supplement containing olive oil (iso-energetic)
Number of subjects: 0
Study: 29422450

Group type: EXPERIMENTAL
Intervention: Emphasizing the incentive in the subject line of the invitation email
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Sending the invitation email on Tuesday
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Sending the invitation email on Friday
Number of subjects: 2000
Study: 27589695

Group type: EXPERIMENTAL
Intervention: Virtual assistance-based lifestyle intervention (mobile phone messages: 3 per week, e-mails: 2 per week for 1 year)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Control group (no additional intervention)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Virtual assistance-based lifestyle intervention
Number of subjects: 265
Study: 26591623

Group type: EXPERIMENTAL
Intervention: Test regimen (TR) including triclosan, PVM/MA copolymer, 0.243% sodium fluoride toothpaste, alcohol-free, fluoride-free CPC mouthwash, and manual toothbrush with cheek and tongue cleaner
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Test regimen (TR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Negative control regimen (NCR) including 0.76% sodium monofluorophosphate toothpaste, fluoride-free and alcohol-free non-antibacterial mouthwash, and manual toothbrush with rounded/polished bristles
Number of subjects: 120
Study: 24160223

Group type: EXPERIMENTAL
Intervention: 12-week aerobic training program, 3 sessions/week, moderate intensity (60-75% HRmax) for 25-40 minutes
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 135
Study: 20621361

Group type: EXPERIMENTAL
Intervention: Active rTMS (10Hz, 90% of resting MT, 20 trains, 6s duration, 1200 pulses/day)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 45
Study: 18978635

Group type: EXPERIMENTAL
Intervention: Active Aftercare (AA) conditions (5-session in-person or brief telephone)
Number of subjects: 177

Group type: COMPARATOR
Intervention: No Active Aftercare (NA)
Number of subjects: 177
Study: 16798303

Group type: EXPERIMENTAL
Intervention: Oral citrulline (1.9 g/m2 per dose, 5 perioperative doses)
Number of subjects: 40
Study: 12930586

Group type: EXPERIMENTAL
Intervention: Day 3 embryo transfer
Number of subjects: 118

Group type: COMPARATOR
Intervention: Day 5 embryo transfer
Number of subjects: 118
Study: 11193299

Group type: EXPERIMENTAL
Intervention: Tamsulosin + Chlormadinone Acetate (CMA)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Tamsulosin
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Tamsulosin + CMA
Number of subjects: 33
Study: 9174878

Group type: COMPARATOR
Intervention: Oral diazepam 0.2 mg/kg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oral clonidine 3 micrograms/kg
Number of subjects: 50
Study: 30058461

Group type: EXPERIMENTAL
Intervention: Unilateral-horizontal plyometric training (UH)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bilateral-vertical plyometric training (BV)
Number of subjects: 20
Study: 29482597

Group type: EXPERIMENTAL
Intervention: General Psychiatric Management (GPM) treatment for BPD
Number of subjects: 99
Study: 27562743

Group type: EXPERIMENTAL
Intervention: Short cycle therapy (5 days on, 2 days off ART)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Continuous therapy (continuous ART)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Short cycle therapy
Number of subjects: 199

Group type: COMPARATOR
Intervention: Continuous therapy
Number of subjects: 199
Study: 23736923

Group type: EXPERIMENTAL
Intervention: Ulinastatin (100,000 units/10 kg) infused 15 min before blood transfusion or after liver resection
Number of subjects: 44

Group type: COMPARATOR
Intervention: Blood transfusion
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Ulinastatin
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Blood transfusion and Ulinastatin (BT+UTI group)
Number of subjects: 44
Study: 22767410

Group type: EXPERIMENTAL
Intervention: Transdiagnostic cognitive-behavioral group treatment (12 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Diagnosis-specific group Cognitive-Behavioral Therapy (CBT) protocols (12 weeks)
Number of subjects: 46
Study: 18557812

Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once daily
Number of subjects: 234
Study: 16448471

Group type: EXPERIMENTAL
Intervention: Dining room group (supervised dining room)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (bedside eating)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Dining room group
Number of subjects: 48
Study: 12716796

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12035205

Group type: EXPERIMENTAL
Intervention: Efficacy-enhancing experimental group (n = 10)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Usual-care control group (n = 8)
Number of subjects: 18
Study: 9426079

Group type: EXPERIMENTAL
Intervention: Inhaled phosphoramidon (10[-5] M)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7506155

Group type: EXPERIMENTAL
Intervention: Nimesulide (200 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bromeline (240 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3541620

Group type: EXPERIMENTAL
Intervention: Routine electronic fetal monitoring
Number of subjects: 7

Group type: COMPARATOR
Intervention: Fetal heart rate monitoring by auscultation
Number of subjects: 7
Study: 30930132

Group type: EXPERIMENTAL
Intervention: Vitamin C (20 mg/kg body weight)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combined supplementation with nitrate (7 mg/kg body weight) and vitamin C
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nitrate (7 mg/kg body weight)
Number of subjects: 20
Study: 29863549

Group type: EXPERIMENTAL
Intervention: Richieri-Costa-Pereira syndrome group
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 9
Study: 27004659

Group type: EXPERIMENTAL
Intervention: Visual feedback for a target hop height
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Tactile feedback for a target hop height
Number of subjects: 27

Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Visual feedback
Number of subjects: 27
Study: 25901838

Group type: EXPERIMENTAL
Intervention: 33-G needle
Number of subjects: 36

Group type: COMPARATOR
Intervention: 30-G needle
Number of subjects: 36
Study: 23934005

Group type: EXPERIMENTAL
Intervention: Adaptive coping strategies
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Maladaptive coping strategies
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Positive affect and social support
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Negative affect
Number of subjects: 168
Study: 20599300

Group type: EXPERIMENTAL
Intervention: Energy providing liquids (EPL) given to infants
Number of subjects: 1368

Group type: COMPARATOR
Intervention: Formula-fed infants (FF)
Number of subjects: 1368
Study: 19391325

Group type: EXPERIMENTAL
Intervention: Spinal stabilisation exercises
Number of subjects: 9
Study: 16875654

Group type: EXPERIMENTAL
Intervention: Antibiotics (metronidazole 250 mg and erythromycin 250 mg at 20 to 24 weeks of gestation 3 times daily for 7 days and metronidazole 250 mg and ampicillin 500 mg every 4 hours during labor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12548304

Group type: EXPERIMENTAL
Intervention: Soya scones (120 mg/day of isoflavones)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Wheat scones (control)
Number of subjects: 20
Study: 10861339

Group type: EXPERIMENTAL
Intervention: Tribulus terrestris (3.21 mg per kg body weight daily)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 9166318

Group type: EXPERIMENTAL
Intervention: Misoprostol 400 micrograms orally (group 1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Misoprostol 800 micrograms vaginally (group 2)
Number of subjects: 20